Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.11 USD | -0.99% | -1.41% | -14.03% |
03:25pm | Everlasting momentum | |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.03% | 9.03TCr | |
+32.36% | 71TCr | |
+30.77% | 60TCr | |
-1.60% | 37TCr | |
+20.07% | 33TCr | |
+6.04% | 29TCr | |
+14.77% | 24TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.27% | 17TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Berenberg Bank Adjusts Bristol-Myers Squibb Price Target to $60 From $76, Maintains Hold Rating